Skip to main content

Inpatient diabetes


10-03-2019 | Ketoacidosis | Highlight | News

Protocol with point-of-care testing improves speed, accuracy of DKA diagnosis

Implementing a nursing protocol that includes point-of-care testing at triage reduces the time to diabetic ketoacidosis diagnosis and the number of unnecessary intravenous placements in the pediatric emergency department, say researchers.

07-09-2019 | Inpatient diabetes | Highlight | News

Holistic approach can shorten diabetes inpatient stays

A nurse-delivered care program based on a whole-systems approach can lead to shorter hospital stays for patients with diabetes, UK researchers report.

04-01-2019 | Artificial pancreas systems | News

Closed-loop insulin feasible for inpatients needing nutritional support

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

11-28-2018 | Linagliptin | News

Linagliptin preferable to insulin in majority of surgical type 2 diabetes patients

Daily linagliptin is effective and reduces hypoglycemia risk relative to multidose insulin in type 2 diabetes patients with mild-to-moderate hyperglycemia who are undergoing non-cardiac surgery, suggest the results of a randomized controlled study.

06-26-2018 | Artificial pancreas systems | Highlight | News

Closed-loop delivery improves inpatient glucose control in type 2 diabetes

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

03-27-2017 | Inpatient diabetes | News

Remote monitoring may improve diabetes inpatient care

A study suggests that use of a virtual glucose management service can reduce hyper- and hypoglycemia among inpatients with diabetes by around a third.

12-09-2016 | Inpatient diabetes | News

DPP-4 inhibition may have role in inpatient diabetes care

Adding the dipeptidyl peptidase-4 inhibitor sitagliptin to basal insulin reduces bolus insulin requirements in hospitalized patients with type 2 diabetes, shows a randomised trial.

11-10-2016 | Artificial pancreas systems | News

Artificial pancreas could meet type 2 diabetes inpatient needs

A pilot randomized trial suggests that closed-loop insulin delivery is feasible for inpatients with insulin-dependent type 2 diabetes on the general ward.

Image Credits